Sonoma Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

5. Accounts Receivable (Tables)

12 Months Ended

Mar. 31, 2017

	March 31,
	2017			2016
Accounts receivable	$	2,794,000		$	2,176,000
Less: allowance for doubtful accounts		(14,000	)		(15,000	)
Less: discounts, rebates, distributor fees and returns		(672,000	)		(653,000	)
	$	2,108,000		$	1,508,000